Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
Author(s) -
Frank Edelmann,
Rolf Wachter,
Albrecht Schmidt,
Elisabeth KraigherKrainer,
Caterina Colantonio,
W. Kamke,
André Duvinage,
Raoul Stahrenberg,
Kathleen Durstewitz,
Markus Löffler,
HansDirk Düngen,
Carsten Tschöpe,
Christoph HerrmannLingen,
Martin Halle,
Gerd Hasenfuß,
Götz Gelbrich,
Burkert Pieske,
for the Aldo-DHF Investigators
Publication year - 2013
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2013.905
Subject(s) - spironolactone , medicine , ejection fraction , heart failure , cardiology , placebo , diastole , aldosterone , diastolic heart failure , blood pressure , alternative medicine , pathology
Diastolic heart failure (ie, heart failure with preserved ejection fraction) is a common condition without established therapy, and aldosterone stimulation may contribute to its progression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom